<DOC>
	<DOCNO>NCT02214615</DOCNO>
	<brief_summary>This research study design investigate brain response use fMRI scan , behavioral response , treatment drug carbamazepine ( CBZ ) patient painful sodium channelopathy inherit Erythromelalgia ( IEM ) . This study design identify central nervous system ( CNS ) region activate ongoing evoked pain attack , alter CNS response CBZ treatment . This advance understand IEM affect brain . We also hope validate pharmacogenic approach study IEM use FDA approve drug . We hope , sure , subject directly benefit study .</brief_summary>
	<brief_title>Carbamazapine Inherited Erythromelalgia Patients With NaV1.7 Mutations</brief_title>
	<detailed_description />
	<mesh_term>Erythromelalgia</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>diagnosis/symptoms EM specific NaV1.7 sodium channel mutation ( include S241T ) patient identify NaV1.7 mutation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>